Dr. John S. Chorba, MD

Dr. Chorba practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Dr. Chorba's NPI, 1538364138, was assigned on June 15, 2007. Dr. Chorba graduated from Harvard Medical School in 2007. Dr. Chorba's Massachusetts license number on file is L-232058.

Dr. Chorba's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Dr. Chorba's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. Dr. Chorba is also affiliated with Banner - University Medical Center Tucson. The medical group on file is UCSF Department of Radiology & Biomedical Imaging. Dmand AI also links Dr. Chorba to 4 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chorba practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chorba's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chorba is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Chorba's licenses on file in 2 states: Massachusetts and California.

Dmand AI lists atrial fibrillation and flutter, coronary artery disease, heart attack, heart failure and syncope & collapse among the conditions Dr. Chorba treats.

CMS data shows 356 Medicare services from Dr. Chorba across 7 procedure codes in 2024, for 249 Medicare patients. Medicare paid $20,933 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 249 Medicare patients who saw Dr. Chorba in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 92% are also on Medicaid. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chorba's median patient age at 60, with 50% women.

In 2024, Dr. Chorba wrote 108 Medicare Part D claims for 21 patients. 77% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $53 in total drug cost. In 2023, CMS named 60 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Chorba for performance year 2024, reported as part of a group. Dr. Chorba accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chorba as offering telehealth.

Dmand AI links 18 papers to Dr. Chorba, published from 2007 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Proprotein Convertase 9, Enzyme Inhibitors and HEK293 Cells. Dr. Chorba has published most often in Bioorg Med Chem Lett. Dr. Chorba's most frequent co-authors are Caroline Julie Currie, MD, Arun Padmanabhan, MD, PhD and Geoffrey A. Smith, MD, PhD.

Dmand AI links Dr. Chorba to 1 clinical trial. Conditions studied include Heart Murmurs and Mitral Valve Insufficiency.

CMS Open Payments shows 8 general payments to Dr. Chorba from 2 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 97% of the total. Eko Devices, Inc. paid the most, $21,818.

Dr. Chorba graduated from Harvard Medical School in 2007. Dr. Chorba is a member of ACC.

Dr. Chorba is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.